Organization Overview
Alternative names
anastrozole (arimidex) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (2 trials)
daptomycin (cubicin) (1 trial)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)
docetaxel (taxotere) (3 trials)
exemestane (aromasin) (1 trial)
fluorouracil (efudex) (2 trials)
allogeneic lymphocytes (1 trial)
amantadine (symmetrel) (1 trial)
antihemophilic factor viii human (Hemofil M) (1 trial)
azacitidine (vidaza) (2 trials)
COVID-19 convalescent plasma (1 trial)
dextromethorphan (delsym) (1 trial)
doxycycline (vibramycin) (1 trial)
durvalumab (imfinzi) (1 trial)
Acanthocheilonemiasis (Phase 2)
Alcoholism (Phase 4)
Alzheimer Disease (Phase 4)
Aortic Valve Stenosis (Phase 2)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Astrocytoma (Phase 3)
Blood Loss, Surgical (Phase 2)
Breast Neoplasms (Phase 3)
Buruli Ulcer (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cardiovascular Diseases (Phase 1)
Central Nervous System Neoplasms (Phase 3)
Coinfection (Phase 2)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 2)
Constriction, Pathologic (Phase 2)
Coronavirus Infections (Phase 2)
Critical Illness (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 3)
Dipetalonema Infections (Phase 2)
Disease Progression (Phase 2)
Fibrosis (Phase 2)
Glioblastoma (Phase 3)
Hand-Foot Syndrome (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hemorrhage (Phase 2)
Infections (Phase 3)
Inflammation (Phase 2)
Keratosis (Phase 2)
Keratosis, Actinic (Phase 2)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Lupus Erythematosus, Cutaneous (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 2)
Mansonelliasis (Phase 2)
Mental Disorders (Phase 4)
Mucopolysaccharidoses (Phase 3)
Mucopolysaccharidosis II (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Myelodysplastic Syndromes (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplastic Cells, Circulating (Phase 3)
Nephritis (Phase 3)
Nervous System Neoplasms (Phase 3)
Oligodendroglioma (Phase 3)
Peripheral Arterial Disease (Phase 2)
Peritoneal Neoplasms (Phase 2)
Preleukemia (Phase 2)
Prodromal Symptoms (Phase 4)
Psychotic Disorders (Phase 4)
Recurrence (Phase 3)
Respiration Disorders (Phase 2)
Respiratory Tract Diseases (Phase 2)
Schizophrenia (Phase 4)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Staphylococcal Infections (Phase 3)
Stroke (Phase 3)
Syndrome (Phase 3)
Thrombocytopenia (Phase 4)
Tobacco Use Disorder (Phase 2)
Tuberculosis (Phase 2)
Ulcer (Phase 2)
Urinary Bladder Neoplasms (Phase 2)